A group of embattled government advisers will meet this week in the first major test of who controls US vaccine policy: scientific experts or
The Advisory Committee on Immunization Practices gathers a few times a year to review data and make recommendations that determine when vaccines are given and whether they are covered by insurance. The influential group, mostly unknown outside of public health circles, normally does business with little fanfare.
But this week, it’s drawing attention as it convenes in Atlanta for the first time since Kennedy, a longtime vaccine critic, became the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
